Dr. Martens
DOCS · Main Market · Consumer Products and Services · mcap £651m · 68.9p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 08 Oct 26 | Director dealing | Director/PDMR Shareholding | |
| 07 Oct 26 | Group Reporting Changes
Dr. Martens moves to market-based reporting with US and Global Markets segments effective FY27. |
+2.6% | |
| 30 Sep 26 | Routine | Admission to Trading | |
| 30 Sep 26 | Routine | Total Voting Rights | |
| 24 Sep 26 | Launch of 'With Bouncing Soles' Brand Platform
Dr. Martens launches 'With Bouncing Soles' brand platform with new ecommerce site and four Brand Centre store openings this autumn. |
+0.7% | |
| 16 Sep 26 | Director dealing | Director/PDMR Shareholding | |
| 01 Sep 26 | Routine | Admission to Trading | |
| 01 Sep 26 | Routine | Total Voting Rights | |
| 13 Aug 26 | Director dealing | Director/PDMR Shareholding | |
| 11 Aug 26 | Holding | Holding(s) in Company | |
| 06 Aug 26 | Board change | Appointment of Independent Non-Executive Director
Alia Gogi appointed as Independent Non-Executive Director, effective 1 September 2026. |
+2.0% |
| 03 Aug 26 | Routine | Admission to Trading | |
| 31 Jul 26 | Routine | Total Voting Rights | |
| 16 Jul 26 | Director dealing | Director/PDMR Shareholding | |
| 15 Jul 26 | Routine | Result of AGM | |
| 15 Jul 26 | Trading update | AGM Trading Update
FY27 guidance unchanged; trading in line with expectations; on track with strategic objectives. |
+2.1% |
| 01 Jul 26 | NED Appointment and Committee Changes
Melanie Richards appointed Independent Non-Executive Director and Senior Independent Director from 15 July 2026. |
+2.6% | |
| 30 Jun 26 | Routine | Admission to Trading | |
| 30 Jun 26 | Routine | Total Voting Rights | |
| 26 Jun 26 | Director dealing | Director/PDMR Shareholding | |
| 16 Jun 26 | Director dealing | Director/PDMR Shareholding | |
| 16 Jun 26 | Routine | CEO share purchase | |
| 08 Jun 26 | Holding | Holding(s) in Company | |
| 05 Jun 26 | Routine | Admission to Trading | |
| 02 Jun 26 | Director dealing | Director/PDMR Shareholding | |
| 02 Jun 26 | Results | Annual Report
2026 Annual Report and Notice of Annual General Meeting |
+0.7% |
| 02 Jun 26 | Routine | Total Voting Rights | |
| 27 May 26 | Board change | Directorate Change
Senior Independent Director Lynne Weedall to step down at July 2026 AGM after six years. |
+4.1% |
| 19 May 26 | EBT Share Purchase
The Company announces that it has recommended that FCM Trust Limited (the "Trustee"), in its capacity as trustee of the Dr Martens plc Employee Benefit Trust (the "Trust"), purchases up to 10m ordinary shares of the Comp |
+3.3% | |
| 19 May 26 | Results | FY26 Results
FY26 adjusted PBT up 61% to £55.0m as business pivots to consumer-first model, revenue in line with guidance. |
+3.3% |
| 14 May 26 | Director dealing | Director/PDMR Shareholding | |
| 01 May 26 | Holding | Holding(s) in Company | |
| 30 Apr 26 | Routine | Total Voting Rights | |
| 29 Apr 26 | Holding | Holding(s) in Company | |
| 16 Apr 26 | Director dealing | Director/PDMR Shareholding | |
| 15 Apr 26 | Director dealing | Director/PDMR Shareholding | |
| 10 Apr 26 | Director dealing | Director/PDMR Shareholding | |
| 08 Apr 26 | Appointment of Market General Managers
Dr. Martens restructures to market general manager model with new executive team led by CEO Nwokorie. |
+5.6% | |
| 31 Mar 26 | Routine | Total Voting Rights | |
| 20 Mar 26 | Holding | Holding(s) in Company | |
| 13 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 27 Feb 26 | Routine | Total Voting Rights | |
| 13 Feb 26 | Director dealing | Director/PDMR Shareholding | |
| 30 Jan 26 | Routine | Total Voting Rights | |
| 29 Jan 26 | EBT Share Purchase
The Company announces that it has recommended that FCM Trust Limited (the "Trustee"), in its capacity as trustee of the Dr Martens plc Employee Benefit Trust (the "Trust"), purchases up to 10m ordinary shares of the Comp |
+2.9% | |
| 27 Jan 26 | Holding | Holding(s) in Company | |
| 27 Jan 26 | Trading update | Q3 FY26 Trading Statement
Q3 revenue down 2.7% on constant currency; wholesale up 9.5% but DTC down 6.5% as promotions cut. |
−11.6% |
| 15 Jan 26 | Director dealing | Director/PDMR Shareholding | |
| 31 Dec 25 | Routine | Total Voting Rights | |
| 12 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 12 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 08 Dec 25 | Director dealing | Director/PDMR Shareholding | |
| 01 Dec 25 | Routine | Block listing Interim Review | |
| 28 Nov 25 | Routine | Total Voting Rights | |
| 25 Nov 25 | Holding | Holding(s) in Company | |
| 20 Nov 25 | Results | H1 FY26 Results
H1 FY26 revenue flat at £322m; adjusted PBT loss improved to £9.2m; full price DTC revenue up 6%. |
−9.6% |
| 12 Nov 25 | Director dealing | Director/PDMR Shareholding | |
| 31 Oct 25 | Routine | Total Voting Rights | |
| 21 Oct 25 | Holding | Holding(s) in Company | |
| 20 Oct 25 | Holding | Holding(s) in Company | |
| 16 Oct 25 | Director dealing | Director/PDMR Shareholding | |
| 14 Oct 25 | Director dealing | Director/PDMR Shareholding | |
| 10 Oct 25 | Appointment of joint corporate broker
Martens plc announces the appointment of Berenberg as joint corporate broker, to work alongside Investec and Goldman Sachs, with immediate effect. |
−3.4% | |
| 09 Oct 25 | Director dealing | Director/PDMR Shareholding |
Company filings. Not investment advice.